Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C

Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C

Background: Whether hepatic resection (HR) could be performed for patients with Barcelona Clinic Liver Cancer (BCLC) B/C stage hepatocellular carcinoma (HCC) is controversial, and the safety and clinical value of HR combined with antiviral therapy for hepatitis B virus (HBV)-related HCC with BCLC-B/...

Full description

Bibliographic Details
Main Authors: Qin Wei, Huan Tian, Huan-xian Luo, Ying-cai Zhang, Yi-nan Deng, Jia Yao, Hua Li, Gui-hua Chen, Yang Yang
Format: Article
Language:English
Published: Elsevier 2017-11-01
Series:Asian Journal of Surgery
Subjects:
antiviral therapy
Barcelona Clinic Liver Cancer
hepatic resection
hepatitis B virus
hepatocellular carcinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S1015958416300306

Internet

http://www.sciencedirect.com/science/article/pii/S1015958416300306

Similar Items